STRATEC Biomedical Systems AG / Dividend 06.03.2009 Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- STRATEC's Board of Management proposes to raise dividend by 59% to Euro 0.35 per share Birkenfeld, March 6, 2009 In view of the future business performance expected at the STRATEC Group, its high volume of liquidity and high equity ratio, the Board of Management of STRATEC Biomedical Systems AG (FSE: SBS, Prime Standard Segment) today resolved to present to the Supervisory Board a proposal for the appropriation of profits for the Annual General Meeting which foresees raising the dividend for the 2008 financial year by 59% to Euro 0.35 per share (previous year: Euro 0.22). --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: About STRATEC STRATEC Biomedical Systems AG (http://www.stratec-biomedical.de) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, to laboratories, blood banks and research institutes around the world. The company develops its products on the basis of its own patented technologies. Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard segment of the Frankfurt Stock Exchange. The STRATEC Group consists of the publicly listed parent company STRATEC Biomedical Systems AG and of subsidiaries and second-tier subsidiaries in Germany, the USA, the UK, Switzerland and Romania. Further information can be obtained from: STRATEC Biomedical Systems AG André Loy, Investor Relations Gewerbestr. 37, 75217 Birkenfeld Germany Phone: +49 7082 7916 190 Fax: +49 7082 7916 999 Email: ir@stratec-biomedical.de DGAP 06.03.2009 --------------------------------------------------------------------------- Language: English Issuer: STRATEC Biomedical Systems AG Gewerbestraße 37 75217 Birkenfeld Deutschland Phone: +49 (0)7082 7916 0 Fax: +49 (0)7082 7916 999 E-mail: info@stratec-biomedical.de Internet: www.stratec-biomedical.de ISIN: DE0007289001 WKN: 728900 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Stuttgart, München, Düsseldorf End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: STRATEC's Board of Management proposes to raise dividend by 59% to Euro 0.35 per share
| Source: EQS Group AG